Krystal Biotech, Inc.
KRYS
$345.70
-$2.40-0.69%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.08% | 8.82% | -35.24% | 107.03% | 7.28% |
| Total Depreciation and Amortization | -49.59% | -4.72% | 48.83% | -5.71% | -14.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.89% | -13.93% | 228.42% | -192.38% | 1.68% |
| Change in Net Operating Assets | -44.26% | 6.16% | 134.07% | -5,743.12% | 102.67% |
| Cash from Operations | -6.96% | 3.71% | 95.44% | -24.79% | 70.26% |
| Capital Expenditure | 50.13% | -234.17% | -25.53% | 10.50% | 69.31% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -180.00% | -524.26% | 615.18% | 70.05% | 82.41% |
| Cash from Investing | -154.13% | -669.59% | 360.45% | 59.28% | 80.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 133.21% | -58.56% | 322.43% | 106.79% | 22.85% |
| Repurchase of Common Stock | 99.36% | -73,639.13% | -360.00% | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 243.92% | -166.76% | 322.38% | 106.51% | 114.41% |
| Foreign Exchange rate Adjustments | -37.57% | -108.95% | -107.49% | -128.99% | 519.30% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,568.82% | -95.17% | 167.44% | -13.95% | 224.83% |